Moreover, the reciprocal regulation of Hsd17b13 expression and fibrosis markers was associated with simple HFD‐induced obesity ± beneficial effects of fenretinide (Figure 1 and 2, GEO number GSE220684). Here, HSD17B13 is linked to obesity due to melanocortin 4 receptor deficiency.